Overview

Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of Sorafenib in combination with Gemcitabine in patients with advanced/unresectable HCC.
Phase:
Phase 2
Details
Lead Sponsor:
Mahidol University
Collaborators:
Bayer
Bumrungrad International Hospital
Chulalongkorn University
Treatments:
Gemcitabine
Niacinamide
Sorafenib